Alx Oncology Holdings Inc (ALXO) Live Share Price, Invest From India

Alx Oncology Holdings Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

Day's Low
Day's High
$2.13
Day's Price Range
$2.27
$2.17
1.84%
Downside
4.61%
Upside
52 Week's Low
52 Week's High
$0.40
52-Week Price Range
$2.66
$2.17
81.38%
Downside
22.58%
Upside

Alx Oncology Holdings Inc share price movements today

Previous Close: $2.19
Open: $2.19
Volume: 678.2K
Day's Low - High: $2.13 - $2.27
52 Week Low - High: $0.40 - $2.66

Alx Oncology Holdings Inc Historical Returns

1 Month Return: -10.61 %
3 Month Return: + 51.03 %
1 Year Return: + 192.59 %
3 Year Return: -52.49 %
5 Year Return: -96.53 %

Alx Oncology Holdings Inc Stock Fundamentals & Key Indicators

Check Alx Oncology Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$283.0M

EPS (TTM)

-0.6493

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-100.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-145.70%

Alx Oncology Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alx Oncology Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Alx Oncology Holdings Inc	BUY	$283.0M	-96.53%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.7B	115.8%	135.11	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$114.7B	111.95%	29.5	32.94%
Beone Medicines Ltd	NA	$32.4B	NA	114.75	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$78.7B	55.68%	17.95	31.41%

Stock Returns calculator for Alx Oncology Holdings Inc Stock including INR - Dollar returns

The Alx Oncology Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Alx Oncology Holdings Inc investment value today

Current value as on today

₹2,97,880

Returns

₹1,97,880

(+197.88%)

Returns from Alx Oncology Holdings Inc Stock

₹1,89,333 (+189.33%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Alx Oncology Holdings Inc Stock

Based on 13 analysts

BUY

84.62%

Buy

15.38%

Hold

0.00%

Sell

Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Alx Oncology Holdings Inc. Average target price of $4.5

Alx Oncology Holdings Inc Share Price Target

Get share price movements and forecasts by analysts on Alx Oncology Holdings Inc.

What analysts predicted

51.78%UPSIDE

Target Price

$4.5

Current Price

$2.17

Analyzed by

13 Analysts

Target

$4.50

Alx Oncology Holdings Inc target price $4.5, a slight upside of 51.78% compared to current price of $2.17. According to 13 analysts rating.

Alx Oncology Holdings Inc Stock’s Investor Sentiment and Interest

Search interest for Alx Oncology Holdings Inc Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 19, 2026 to March 21, 2026

Change:11% versus previous 30 day period

Alx Oncology Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	2	-	-	-	0	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-	-
Operating Income	-53	-48	-37	-41	-32	-30	-31	-26	-22	-23
EBITDA	-50	-44	-34	-38	-30	-28	-30	-25	-21	-23
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-50	-45	-35	-39	-30	-29	-30	-25	-22	-22
Income Tax Expense	0	1	0	-	-	-	-	-	-	-
Net Income	-50	-45	-35	-39	-30	-29	-30	-25	-22	-22
Net Profit Margin	0.00%	-1833.55%	0.00%	0.00%	0.00%	-3359.79%	0.00%	0.00%	0.00%	0.00%

Alx Oncology Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	2	4	1	-	-	-	-	-
Gross Profit	0	0	0	0	-1	0	0	-
Operating Income	-13	-19	-43	-83	-127	-170	-142	-100
EBITDA	-13	-18	-43	-83	-127	-158	-132	-100
Interest Expense	-	0	0	0	4	1	1	1
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-13	-19	-45	-83	-123	-160	-134	-101
Income Tax Expense	0	0	0	0	0	-	-	-
Net Income	-13	-19	-45	-83	-123	-160	-134	-101
Net Profit Margin	-664.30%	-401.23%	-3869.71%	0.00%	0.00%	0.00%	0.00%	0.00%

Alx Oncology Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-45	-35	-39	-30	-29	-30	-25	-22	-22
Operating Cash Flow	-39	-37	-26	-25	-32	-24	-23	-17	-18
Investing Cash Flow	-16	26	0	25	33	27	22	21	11
Financing Cash Flow	59	3	27	0	0	0	0	0	0
Change in Cash	2	-8	1	0	1	3	-1	4	-7

Alx Oncology Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-45	-83	-123	-160	-134	-101
Operating Cash Flow	-14	-38	-68	-89	-130	-121	-84
Investing Cash Flow	0	0	-4	-235	44	86	82
Financing Cash Flow	15	462	2	9	59	30	0
Change in Cash	0	425	-70	-314	-26	-4	-1

Global Institutional Holdings in Alx Oncology Holdings Inc

Funds	Holdings
Almitas Capital LLC	3.87%
Susquehanna International Group, LLP	0.12%
venBio Partners LLC	7.38%
Redmile Group, LLC	2.54%
Almitas Capital LLC	1.93%

See all

Insights on Alx Oncology Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ALXO stock has moved up by 10.6%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ALXO has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 65.9% return, outperforming this stock by 118.4%

About Alx Oncology Holdings Inc

alx oncology (previously alexo therapeutics) is a clinical-stage immuno-oncology company developing therapies that block the cd47 myeloid checkpoint mechanism exploited by cancer cells to evade the immune system. our lead candidate, alx148, is a fusion protein that comprises an engineered high affinity cd47 binding domain of sirpa linked to an inactive fc region of human immunoglobulin. alx148 is currently being investigated in a phase 1 study in combination with checkpoint inhibitors and targeted anti-cancer antibodies (nct03013218). for more information about the company, please visit our website at www.alxoncology.com

Organisation	Alx Oncology Holdings Inc
Headquarters	323 Allerton Avenue, South San Francisco, CA, United States, 94080
Industry	Commercial Services
CEO	Mr. Jason W. Lettmann
E-voting on shares	Click here to vote

Key Management of Alx Oncology Holdings Inc

Name	Title
Ms. Shelly Pinto CPA	Senior VP of Finance & Chief Accounting Officer
Ms. Sue Naim	Senior Vice President of Clinical Operations
Mr. Jason W. Lettmann	CEO & Director
Mr. Harish Shantharam C.F.A.	Chief Financial Officer
Dr. Athanasios Tsiatis M.D.	Senior Vice President of Clinical Development
Dr. Lin Yeong-Liang M.D., M.S.	Senior Vice President of Drug Safety & Pharmacovigilance
Ms. Lisa Sauer	Senior Vice President of Regulatory Affairs & Quality Assurance
Ms. Venita De Almeida Ph.D.	VP & Head of Research Program Development
Dr. Barbara J. Klencke M.D.	Chief Medical Officer

FAQs

What is Alx Oncology Holdings Inc share price today?

Alx Oncology Holdings Inc share price today is $2.17 as on March 21, 2026 at 1:29 am IST at the close of the market. Alx Oncology Holdings Inc share today touched a day high of $2.27 and a low of $2.13.

What is the 52 week high and 52 week low for Alx Oncology Holdings Inc share?

Alx Oncology Holdings Inc share touched a 52 week high of $2.66 on February 19, 2026 and a 52 week low of $0.4 on June 27, 2025. Alx Oncology Holdings Inc stock price today i.e. March 21, 2026 at 1:29 am IST is closed at $2.17,which is 18.42% down from its 52 week high and 437.13% up from its 52 week low.

What is Alx Oncology Holdings Inc's market capitalisation today?

Alx Oncology Holdings Inc market capitalisation is $0.00T as on March 21, 2026 at 1:29 am IST.

How to invest in Alx Oncology Holdings Inc Stock (ALXO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Alx Oncology Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alx Oncology Holdings Inc Shares that will get you 0.6912 shares as per Alx Oncology Holdings Inc share price of $2.17 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Alx Oncology Holdings Inc Stock (ALXO) from India?

Indian investors can start investing in Alx Oncology Holdings Inc (ALXO) shares with as little as ₹93.708 or $1 (as of March 21, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Alx Oncology Holdings Inc stock (as per the Rupee-Dollar exchange rate as on March 21, 2026 at 5:40 am IST). Based on Alx Oncology Holdings Inc share’s latest price of $2.17 as on March 21, 2026 at 1:29 am IST, you will get 4.6083 shares of Alx Oncology Holdings Inc. Learn more about fractional shares .

What are the returns that Alx Oncology Holdings Inc has given to Indian investors in the last 5 years?

Alx Oncology Holdings Inc stock has given -96.53% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?